IL-6 has proven to be a valuable biomarker in guiding therapeutic decisions, particularly regarding the initiation, type, and duration of antibiotic treatment: Elevated IL-6 levels at hospital admission may reflect an active systemic inflammatory response due to bacterial infection (Akira et al., 1993) [49]. The gene discussed is IL6; the disease is bacterial infectious disease.